Annual EBITDA
-$101.73 M
-$4.87 M-5.03%
December 31, 2023
Summary
- As of February 7, 2025, SLDB annual EBITDA is -$101.73 million, with the most recent change of -$4.87 million (-5.03%) on December 31, 2023.
- During the last 3 years, SLDB annual EBITDA has fallen by -$19.19 million (-23.25%).
- SLDB annual EBITDA is now -1449.88% below its all-time high of -$6.56 million, reached on December 31, 2015.
Performance
SLDB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$32.24 M
-$8.49 M-35.74%
September 30, 2024
Summary
- As of February 7, 2025, SLDB quarterly EBITDA is -$32.24 million, with the most recent change of -$8.49 million (-35.74%) on September 30, 2024.
- Over the past year, SLDB quarterly EBITDA has dropped by -$3.48 million (-12.09%).
- SLDB quarterly EBITDA is now -271.11% below its all-time high of -$8.69 million, reached on December 31, 2016.
Performance
SLDB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$108.63 M
-$11.95 M-12.36%
September 30, 2024
Summary
- As of February 7, 2025, SLDB TTM EBITDA is -$108.63 million, with the most recent change of -$11.95 million (-12.36%) on September 30, 2024.
- Over the past year, SLDB TTM EBITDA has dropped by -$6.89 million (-6.78%).
- SLDB TTM EBITDA is now -1150.49% below its all-time high of -$8.69 million, reached on December 31, 2016.
Performance
SLDB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SLDB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.0% | -12.1% | -6.8% |
| 3 y3 years | -23.3% | -35.4% | -6.8% |
| 5 y5 years | -37.3% | -35.4% | -6.8% |
SLDB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | at low | -80.2% | at low | -56.8% | at low |
| 5 y | 5-year | -46.8% | +12.7% | -99.6% | at low | -56.8% | +6.8% |
| alltime | all time | -1449.9% | +12.7% | -271.1% | at low | -1150.5% | +6.8% |
Solid Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.24 M(+35.7%) | -$108.63 M(+12.4%) |
| Jun 2024 | - | -$23.75 M(-0.6%) | -$96.68 M(-0.1%) |
| Mar 2024 | - | -$23.88 M(-17.0%) | -$96.74 M(-4.9%) |
| Dec 2023 | -$101.73 M(+5.0%) | -$28.76 M(+41.8%) | -$101.73 M(+0.4%) |
| Sep 2023 | - | -$20.29 M(-14.8%) | -$101.34 M(-0.4%) |
| Jun 2023 | - | -$23.82 M(-17.5%) | -$101.75 M(+0.7%) |
| Mar 2023 | - | -$28.87 M(+1.8%) | -$101.08 M(+4.3%) |
| Dec 2022 | -$96.87 M(+39.8%) | -$28.37 M(+37.1%) | -$96.87 M(+12.1%) |
| Sep 2022 | - | -$20.69 M(-10.6%) | -$86.39 M(+4.1%) |
| Jun 2022 | - | -$23.14 M(-6.2%) | -$82.97 M(+6.7%) |
| Mar 2022 | - | -$24.66 M(+37.8%) | -$77.80 M(+12.3%) |
| Dec 2021 | -$69.29 M(-16.1%) | -$17.89 M(+3.5%) | -$69.29 M(-3.7%) |
| Sep 2021 | - | -$17.28 M(-3.8%) | -$71.95 M(-4.2%) |
| Jun 2021 | - | -$17.97 M(+11.2%) | -$75.13 M(+0.4%) |
| Mar 2021 | - | -$16.15 M(-21.4%) | -$74.80 M(-9.4%) |
| Dec 2020 | -$82.54 M | -$20.55 M(+0.4%) | -$82.54 M(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$20.46 M(+16.0%) | -$93.51 M(-8.3%) |
| Jun 2020 | - | -$17.64 M(-26.2%) | -$102.01 M(-7.8%) |
| Mar 2020 | - | -$23.89 M(-24.2%) | -$110.68 M(-5.0%) |
| Dec 2019 | -$116.49 M(+57.2%) | -$31.52 M(+8.9%) | -$116.49 M(+9.0%) |
| Sep 2019 | - | -$28.95 M(+10.0%) | -$106.88 M(+10.7%) |
| Jun 2019 | - | -$26.31 M(-11.4%) | -$96.53 M(+9.6%) |
| Mar 2019 | - | -$29.71 M(+35.6%) | -$88.08 M(+18.8%) |
| Dec 2018 | -$74.12 M(+36.2%) | -$21.91 M(+17.7%) | -$74.12 M(+10.4%) |
| Sep 2018 | - | -$18.61 M(+4.1%) | -$67.15 M(+8.1%) |
| Jun 2018 | - | -$17.86 M(+13.5%) | -$62.13 M(+10.8%) |
| Mar 2018 | - | -$15.75 M(+5.4%) | -$56.09 M(+3.1%) |
| Dec 2017 | -$54.41 M(+113.2%) | -$14.94 M(+10.0%) | -$54.41 M(+13.0%) |
| Sep 2017 | - | -$13.59 M(+14.9%) | -$48.16 M(+39.3%) |
| Jun 2017 | - | -$11.82 M(-15.9%) | -$34.57 M(+52.0%) |
| Mar 2017 | - | -$14.06 M(+61.9%) | -$22.75 M(+161.9%) |
| Dec 2016 | -$25.52 M(+288.8%) | -$8.69 M | -$8.69 M |
| Dec 2015 | -$6.56 M | - | - |
FAQ
- What is Solid Biosciences annual EBITDA?
- What is the all time high annual EBITDA for Solid Biosciences?
- What is Solid Biosciences annual EBITDA year-on-year change?
- What is Solid Biosciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Solid Biosciences?
- What is Solid Biosciences quarterly EBITDA year-on-year change?
- What is Solid Biosciences TTM EBITDA?
- What is the all time high TTM EBITDA for Solid Biosciences?
- What is Solid Biosciences TTM EBITDA year-on-year change?
What is Solid Biosciences annual EBITDA?
The current annual EBITDA of SLDB is -$101.73 M
What is the all time high annual EBITDA for Solid Biosciences?
Solid Biosciences all-time high annual EBITDA is -$6.56 M
What is Solid Biosciences annual EBITDA year-on-year change?
Over the past year, SLDB annual EBITDA has changed by -$4.87 M (-5.03%)
What is Solid Biosciences quarterly EBITDA?
The current quarterly EBITDA of SLDB is -$32.24 M
What is the all time high quarterly EBITDA for Solid Biosciences?
Solid Biosciences all-time high quarterly EBITDA is -$8.69 M
What is Solid Biosciences quarterly EBITDA year-on-year change?
Over the past year, SLDB quarterly EBITDA has changed by -$3.48 M (-12.09%)
What is Solid Biosciences TTM EBITDA?
The current TTM EBITDA of SLDB is -$108.63 M
What is the all time high TTM EBITDA for Solid Biosciences?
Solid Biosciences all-time high TTM EBITDA is -$8.69 M
What is Solid Biosciences TTM EBITDA year-on-year change?
Over the past year, SLDB TTM EBITDA has changed by -$6.89 M (-6.78%)